Propranolol: useful therapeutic agent for the treatment of ulcerated infantile hemangiomas

被引：30

作者：

Kim, Lawrence H. C. ^{[1
]}

Hogeling, Marcia ^{[2
]}

Wargon, Orli ^{[2
]}

Jiwane, Ashish ^{[1
]}

Adams, Susan ^{[1
]}

机构：

[1] Sydney Childrens Hosp, Dept Pediat Surg, Randwick, NSW, Australia

[2] Sydney Childrens Hosp, Dept Pediat Dermatol, Randwick, NSW, Australia

来源：

JOURNAL OF PEDIATRIC SURGERY | 2011年 / 46卷 / 04期

关键词：

Ulceration; Infantile hemangioma; Propranolol; PULSED-DYE-LASER; CAPILLARY ENDOTHELIAL-CELLS; GROWTH-FACTOR; CLINICAL CHARACTERISTICS; CUTANEOUS HEMANGIOMAS; INFANCY; MANAGEMENT; COMPLICATIONS; INVOLUTION; APOPTOSIS;

D O I：

10.1016/j.jpedsurg.2011.01.012

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

Infantile hemangioma (IH) is the most common vascular tumor in early childhood. Ulceration is the most frequent complication, and its management can be challenging. We present 6 cases of ulcerated IH at a single pediatric center, which responded to oral propranolol within 2 to 6 weeks. We recommend that oral propranolol therapy be considered for the management of ulcerated IH as first-line treatment. Crown Copyright (C) 2011 Published by Elsevier Inc. All rights reserved.

引用

页码：759 / 763

页数：5

共 50 条

[41] Retrospective Study of the Treatment of Infantile Hemangiomas Using a Combination of Propranolol and Pulsed Dye Laser
Reddy, Kavitha K.
Blei, Francine
Brauer, Jeremy A.
Waner, Milton
Anolik, Robert
Bernstein, Leonard
Brightman, Lori
Hale, Elizabeth
Karen, Julie
Weiss, Elliot
Geronemus, Roy G.
DERMATOLOGIC SURGERY, 2013, 39 (06) : 923 - 933
[42] Propranolol as First-Line Treatment for Infantile Hemangiomas
Holmes, Will J. M.
Mishra, Anuj
Gorst, Cath
Liew, Se-Hwang
PLASTIC AND RECONSTRUCTIVE SURGERY, 2010, 125 (01) : 420 - 421
[43] Propranolol Treatment in Infantile Hemangiomas: A Single Center Experience
Karatekin, Seyma
Aycicek, Ali
Gundogdu, Muge
Aldemir, Huseyin
JOURNAL OF CHILD - COCUK DERGISI, 2023, 23 (01): : 84 - 88
[44] Early propranolol treatment of infantile hemangiomas improves outcome
Giachetti, Ana
Diaz, Maria Sol
Boggio, Paula
Martinez, Maria Lourdes Posadas
ANAIS BRASILEIROS DE DERMATOLOGIA, 2023, 98 (03) : 310 - 315
[45] Initial experience using propranolol as the sole treatment for infantile airway hemangiomas
Maturo, Stephen
Hartnick, Christopher
INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY, 2010, 74 (03) : 323 - 325
[46] Propranolol versus Prednisone in the Treatment of Infantile Hemangiomas: A Retrospective Comparative Study
Bertrand, Janie
McCuaig, Catherine
Dubois, Josee
Hatami, Afshin
Ondrejchak, Sandra
Powell, Julie
PEDIATRIC DERMATOLOGY, 2011, 28 (06) : 649 - 654
[47] Infantile Hemangiomas - Role of Propranolol
Menon, Prema
Rao, K. L. N.
INDIAN PEDIATRICS, 2013, 50 (05) : 517 - 517
[48] Propranolol-Loaded Mesoporous Silica Nanoparticles for Treatment of Infantile Hemangiomas
Wu, Haiwei
Wang, Xuan
Zheng, Jiawei
Zhang, Ling
Li, Xiaoming
Yuan, Wei-En
Liu, Xuejian
ADVANCED HEALTHCARE MATERIALS, 2019, 8 (09)
[49] Serum levels of VEGF and bFGF in infantile hemangiomas treated with propranolol
Sen, Hilal Susam
Yalcin, Bilgehan
Canpinar, Hande
Ocak, Suheyla
Akyuz, Canan
TURKISH JOURNAL OF PEDIATRICS, 2020, 62 (06) : 979 - 985
[50] Infantile Hemangiomas Pathogenesis and Review of Propranolol Use
Laken, Patricia Ann
ADVANCES IN NEONATAL CARE, 2016, 16 (02) : 135 - 142

← 1 2 3 4 5 →